Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
The British Journal of Diabetes & Vascular Disease
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Feher, M.
Right arrow Articles by Munro, N.
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Editorial

Management of hyperglycaemia in type 2 diabetes: a clinician's algorithm

Michael Feher

Beta Cell Diabetes Centre, Chelsea & Westminster Hospital, London, UK, michael.feher{at}chelwest.nhs.uk

Alison Cox

Beta Cell Diabetes Centre, Chelsea & Westminster Hospital, London, UK

Neil Munro

Beta Cell Diabetes Centre, Chelsea & Westminster Hospital, London, UK

References

  • Nathan DM, Buse JB, Davidson MB et al. Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Diabetologia 2006;49:1711-21.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Nathan DM, Buse JB, Davidson MB et al. Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Update regarding the thiazolidinediones. Diabetologia 2008;51:8-11.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • N.Bailey CJ, Day C., Campbell IW A consensus algorithm for treating hyperglycaemia in type 2 diabetes. Br J Diabetes Vasc Dis 2006;6:147-8.[Free Full Text]
  • Feher MD, Al-Mrayat M., Brake J., Leong K. Tolerability of prolonged-release metformin (Glucophage® SR) in individuals intolerant to standard metformin. Results from four UK centres. Br J Diabetes Vasc Dis 2007;7:225-8.
  • Day C. New therapies available for the treatment of diabetes. Eur Diabetes Nursing 2006;3:65-70.[CrossRef]
  • Munro N., Levy J. Gut hormones, incretin mimetics and gliptins: New understanding and novel therapies in type 2 diabetes. Primary Care Diabetes 2007;1:103-05.[CrossRef][Medline] [Order article via Infotrieve]
  • Munro N., Levy J., El-Gayer H., Feher M. New therapies for diabetes: Incretin mimetics and gliptins. Diabetes and Primary Care 2007;9:72-80.

The British Journal of Diabetes & Vascular Disease, Vol. 8, No. 1, 3-4 (2008)
DOI: 10.1177/14746514080080010101
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Feher, M.
Right arrow Articles by Munro, N.
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?